This is based on previous studies implicating CACNA1I mutations in neuronal excitability and resultant neurological disorders, coupled with high corticothalamic expression of CACNA1I, and potential connections to established migraine symptom-related neural pathways (Noseda et al., 2011). Here, CACNA1I is linked to migraine disorder.